Inventor · disambiguated record
Kwang Ok Lee
Also filed as: LEE KWANG OK
8 granted patents·2 pending applications·57 citations·filing 1997–2021
84Inventor score
Files withHANMI SCIENCE CO LTD3HANMI PHARM IND CO LTD2YUNGJIN PHARMACEUTICAL CO LTD2BUKWANG PHARMACEUTICAL CO LTD1CHA MI YOUNG1
Top patents by PatentIndex Score
10 records- 0188US8957065B2Fused pyrimidine derivatives for inhibition of tyrosine kinase activityCHA MI YOUNG·Filed 2011·Granted Feb 17, 2015·20 cites·27 claims
- 0281US9345719B2Fused pyrimidine derivatives for inhibition of tyrosine kinase activityHANMI SCIENCE CO LTD·Filed 2014·Granted May 24, 2016·4 cites·31 claims
- 0380US8188102B2Amide derivative for inhibiting the growth of cancer cellsLEE KWANG-OK·Filed 2008·Granted May 29, 2012·15 cites·4 claims
- 0476US6388091B1Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-{(2-methyl-1H-imidazol-1-yl)methyl}-4H-carbazol-4-oneHANMI PHARM IND CO LTD·Filed 2001·Granted May 14, 2002·12 cites·9 claims
- 0569USRE46511EFused pyrimidine derivatives for inhibition of tyrosine kinase activityHANMI SCIENCE CO LTD·Filed 2011·Granted Aug 15, 2017·1 cites·54 claims
- 0652US2016229868A1Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activityHANMI SCIENCE CO LTD·Filed 2016·Application pending·0 cites
- 0751US6130336AProcess for preparing paclitaxelHANMI PHARM IND CO LTD·Filed 1997·Granted Oct 10, 2000·5 cites·30 claims
- 0851US2023095520A1Pharmaceutical composition for preventing or treating cancer comprising azole derivatives or pharmaceutically acceptable salt thereofYUNGJIN PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0944US12110299B2Thiazole derivatives and pharmaceutically acceptable salts thereofYUNGJIN PHARMACEUTICAL CO LTD·Filed 2019·Granted Oct 8, 2024·0 cites·17 claims
- 1038US11254645B2Method for preparing tolimidone on large scaleBUKWANG PHARMACEUTICAL CO LTD·Filed 2018·Granted Feb 22, 2022·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Kwang Ok Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →